Rightslink® by Copyright Clearance Center

Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial

Author:

Li Zhang,Shenglin Ma,Xiangqun Song,Baohui Han,Ying Cheng,Cheng Huang,Shujun Yang,Xiaoqing Liu,Yunpeng Liu,Shun Lu,Jie Wang,Shucai Zhang,Caicun Zhou,Xiangwei Zhang,Nobuya Hayashi,Mengzhao Wang

Publication:

The Lancet Oncology

Publisher:

Elsevier

Date:

May 2012

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Welcome to RightsLink

has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing this content.

I would like to...This drop down menu contains the options the publisher has agreed to permit for reuse of their copyrighted material. The publisher offers these types of use either directly through RightsLink or after approval by the publisher. Please reference the terms and conditions offered during the order process for a complete understanding of the use you select. Need more info?